1st Quarter - Amendment
FAEGRE DRINKER BIDDLE & REATH LLP for INTERNATIONAL MYELOMA FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 13, 2018 | $40,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 18, 2018 | $40,000 | Replaced |
| 1st Quarter - Amendment | Aug 1, 2019 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1409 The Cancer Drug Parity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHIL GINGREY | — |
| JONATHAN M. HEPPEN | — |
| TONY MITCHELL | — |
| JEREMY SCOTT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.